MEDARBOR LLC NPI 1477076941

NPI Details

MEDARBOR LLC is a clinical medical laboratory in Bristol, PA. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. MEDARBOR LLC NPI is 1477076941. The provider is registered as an organization entity type.
The provider Is Doing Business As Medarbor Diagnostics.

The provider's business location address is:

200 RITTENHOUSE CIRCLE EAST BUILDING SUITE 1
BRISTOL, PA
ZIP 19007-625
Phone: (888) 590-0808

The provider's authorized official is Matthew Legowski .
The authorized official title is Operation and has the following contact phone number (609) 703-5097.

The CLIA number assigned to this NPI record is 10D2243236 - other - rapid covid testing site with a certificate type of Certificate of Waiver.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for organism, quantification (HCPCS:87799)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique (HCPCS:87541)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for legionella pneumophila (water borne bacteria), quantification (HCPCS:87542)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Automated urinalysis test (HCPCS:81003)
• Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique (HCPCS:87634)
• Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
• Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Bacterial urine culture (HCPCS:87088)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Bacterial colony count, urine (HCPCS:87086)
• Hemoglobin a1c level (HCPCS:83036)
• Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Screening test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) neutralizing antibody (HCPCS:86408)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
• Measurement of neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:86409)
• Iron level (HCPCS:83540)
• Apolipoprotein level (HCPCS:82172)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Magnesium level (HCPCS:83735)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Vitamin d-3 level (HCPCS:82306)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0480)
• Testosterone (hormone) level, total (HCPCS:84403)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Procalcitonin (hormone) level (HCPCS:84145)
• Insulin measurement, total (HCPCS:83525)
• Blood test, clotting time (HCPCS:85610)
• Uric acid level, blood (HCPCS:84550)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Kidney function blood test panel (HCPCS:80069)
• Creatine kinase (cardiac enzyme) level, mb fraction only (HCPCS:82553)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Progesterone (reproductive hormone) level (HCPCS:84144)
• Gonadotropin, follicle stimulating (reproductive hormone) level (HCPCS:83001)
• Gonadotropin, luteinizing (reproductive hormone) level (HCPCS:83002)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Detection test by nucleic acid for herpes simplex virus, amplified probe technique (HCPCS:87529)
• Rheumatoid factor analysis (HCPCS:86430)
• Hepatitis c antibody measurement (HCPCS:86803)
• Immunologic analysis for autoimmune disease, without titration (HCPCS:86806)
• Ferritin (blood protein) level (HCPCS:82728)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 6-11 targets (HCPCS:87506)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Ammonia level (HCPCS:82140)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Valproic acid level, free (HCPCS:80165)
• Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 12-25 targets (HCPCS:87507)
• Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
• Measurement of total estradiol (hormone) (HCPCS:82670)
• Folic acid level, serum (HCPCS:82746)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Homocysteine (amino acid) level (HCPCS:83090)
• Liver function blood test panel (HCPCS:80076)

The enumeration date for this NPI number is 7/17/2017 and was last updated on 5/17/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: